Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37476 - 37500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	HTATIP2	10553	upregulated	entinostat results in increased expression of HTATIP2 mRNA	11p15.1	A21035
Entinostat	Investigational	HTR2C	3358	upregulated	entinostat results in increased expression of HTR2C mRNA	Xq23	A21037
Entinostat	Investigational	HTR3A	3359	upregulated	entinostat results in increased expression of HTR3A mRNA	11q23.2	A21037
Entinostat	Investigational	HTR7P1	93164	upregulated	entinostat results in increased expression of HTR7P1 mRNA	12p13.1	A21035
Entinostat	Investigational	HYAL1	3373	upregulated	entinostat results in increased expression of HYAL1 mRNA	3p21.31	A21035
Entinostat	Investigational	ICAM1	3383	upregulated	entinostat results in increased expression of ICAM1 mRNA	19p13.2	A21037
Entinostat	Investigational	ICAM2	3384	downregulated	entinostat results in decreased expression of ICAM2 mRNA	17q23.3	A21035
Entinostat	Investigational	ICAM3	3385	upregulated	entinostat results in increased expression of ICAM3 mRNA	19p13.2	A21037
Entinostat	Investigational	ICAM4	3386	upregulated	entinostat results in increased expression of ICAM4 mRNA	19p13.2	A21037 A21035
Entinostat	Investigational	ID3	3399	upregulated	entinostat results in increased expression of ID3 mRNA	1p36.12	A21035
Entinostat	Investigational	IDH1-AS1	100507475	upregulated	entinostat results in increased expression of IDH1-AS1 mRNA	2q34	A21035
Entinostat	Investigational	IDH3A	3419	upregulated	entinostat results in increased expression of IDH3A mRNA	15q25.1	A21037
Entinostat	Investigational	IDI1	3422	downregulated	entinostat results in decreased expression of IDI1 mRNA	10p15.3	A21035
Entinostat	Investigational	IDO1	3620	upregulated	entinostat results in increased expression of IDO1 mRNA	8p11.21	A21037
Entinostat	Investigational	IFI30	10437	upregulated	entinostat results in increased expression of IFI30 mRNA	19p13.11	A21037 A21035
Entinostat	Investigational	IFI6	2537	upregulated	entinostat results in increased expression of IFI6 mRNA	1p35.3	A21035
Entinostat	Investigational	IFITM1	8519	upregulated	entinostat results in increased expression of IFITM1 mRNA	11p15.5	A21037
Entinostat	Investigational	IFITM3	10410	upregulated	entinostat results in increased expression of IFITM3 mRNA	11p15.5	A21037
Entinostat	Investigational	IFNLR1	163702	upregulated	entinostat results in increased expression of IFNLR1 mRNA	1p36.11	A21035
Entinostat	Investigational	IFT57	55081	downregulated	entinostat results in decreased expression of IFT57 mRNA	3q13.12-q13.13	A21037
Entinostat	Investigational	IGF2BP1	10642	upregulated	entinostat results in increased expression of IGF2BP1 mRNA	17q21.32	A21037
Entinostat	Investigational	IGFBP3	3486	downregulated	entinostat results in decreased expression of IGFBP3 mRNA	7p12.3	A21037
Entinostat	Investigational	IGFBP5	3488	downregulated	entinostat results in decreased expression of IGFBP5 mRNA	2q35	A21037
Entinostat	Investigational	IGFBP7	3490	upregulated	entinostat results in increased expression of IGFBP7 mRNA	4q12	A21037
Entinostat	Investigational	IGFBPL1	347252	upregulated	entinostat results in increased expression of IGFBPL1 mRNA	9p13.1	A21037

Displaying entries 37476 - 37500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability